{"data":[{"accessionNo":"0001193125-26-352285","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":"75383L102","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Third Rock Ventures V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6280525,"percentOfClass":13.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001193125-26-352285","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":"75383L102","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Third Rock Ventures GP V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":6280525,"percentOfClass":13.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001193125-26-352285","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":"75383L102","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"TRV GP V, LLC","reportingCik":null,"personType":"OO","sharesOwned":6280525,"percentOfClass":13.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001172661-26-003693","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":"75383L102","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2657521,"percentOfClass":5.56,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001172661-26-003693","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":"75383L102","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Bihua Chen","reportingCik":null,"personType":"HC,IN","sharesOwned":2657521,"percentOfClass":5.56,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001193125-26-352285","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":"75383L102","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Third Rock Ventures VI, L.P.","reportingCik":null,"personType":"PN","sharesOwned":969218,"percentOfClass":2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001193125-26-352285","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":"75383L102","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Third Rock Ventures GP VI, L.P.","reportingCik":null,"personType":"PN","sharesOwned":969218,"percentOfClass":2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001193125-26-352285","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":"75383L102","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"TRV GP VI, LLC","reportingCik":null,"personType":"OO","sharesOwned":969218,"percentOfClass":2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001562230-26-000114","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":"75383L102","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Capital International Investors","reportingCik":null,"personType":"IA","sharesOwned":2921958,"percentOfClass":6.1,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001172661-26-002222","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":"75383L102","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2957521,"percentOfClass":6.19,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001172661-26-002222","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":"75383L102","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Bihua Chen","reportingCik":null,"personType":"HC,IN","sharesOwned":2957521,"percentOfClass":6.19,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001172661-26-001034","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3027521,"percentOfClass":6.35,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001172661-26-001034","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Bihua Chen","reportingCik":null,"personType":"HC,IN","sharesOwned":3027521,"percentOfClass":6.35,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0002012383-26-000711","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0002012593","issuerName":"RAPPORT THERAPEUTICS INC","ticker":"RAPP","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2397549,"percentOfClass":5.03,"filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001172661-25-004952","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"Bihua Chen","reportingCik":null,"personType":"HC,IN","sharesOwned":3192521,"percentOfClass":6.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001172661-25-004952","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-09-30","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3192521,"percentOfClass":6.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0000904454-25-000502","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"JOHNSON & JOHNSON","reportingCik":null,"personType":"CO","sharesOwned":1784517,"percentOfClass":4.9,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0000904454-25-000502","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-30","reportingPerson":"Johnson & Johnson Innovation - JJDC, Inc.","reportingCik":null,"personType":"CO","sharesOwned":1784517,"percentOfClass":4.9,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001104659-25-091350","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-11","reportingPerson":"Dr. James I. Healy (\"Healy\")","reportingCik":null,"personType":"IN","sharesOwned":1947579,"percentOfClass":4.2,"filedAt":"2025-09-18","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001104659-25-091350","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-11","reportingPerson":"Dr. Maha Katabi (\"Katabi\")","reportingCik":null,"personType":"IN","sharesOwned":1863327,"percentOfClass":4,"filedAt":"2025-09-18","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001104659-25-091350","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-11","reportingPerson":"Sofinnova Venture Partners XI, L.P. (\"SVP XI\")","reportingCik":"0001882303","personType":"PN","sharesOwned":1863327,"percentOfClass":4,"filedAt":"2025-09-18","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001104659-25-091350","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-11","reportingPerson":"Sofinnova Management XI, L.P. (\"SM XI LP\")","reportingCik":null,"personType":"PN","sharesOwned":1863327,"percentOfClass":4,"filedAt":"2025-09-18","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"},{"accessionNo":"0001104659-25-091350","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002012593","issuerName":"Rapport Therapeutics, Inc.","ticker":"RAPP","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-11","reportingPerson":"Sofinnova Management XI, L.L.C. (\"SM XI LLC\")","reportingCik":null,"personType":"OO","sharesOwned":1863327,"percentOfClass":4,"filedAt":"2025-09-18","canonicalUrl":"https://xoomar.com/markets/stocks/rapp"}],"updatedAt":"2026-11-05T13:01:52.158Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/rapp","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}